megestrol has been researched along with Cardiovascular Diseases in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lello, S | 1 |
| Basdevant, A; Conard, J; Degrelle, H; Denis, C; Guyene, TT; Ochsenbein, E; Thomas, JL | 1 |
| Cefalu, WT; Greaves, KA; Thomas, MJ; Wagner, JD; Williams, JK; Zhang, L | 1 |
| Luzuy, F; Martin-Du Pan, RC | 1 |
| Capizzi, RL; Case, LD; Cooper, MR; Cruz, J; Jackson, D; Muss, HB; Powell, BL; Richards, F; Spurr, CL; White, D | 1 |
| Babaian, RJ; Johnson, DE; Swanson, DA; Tenney, D; von Eschenbach, AC; Wishnow, KI | 1 |
3 review(s) available for megestrol and Cardiovascular Diseases
| Article | Year |
|---|---|
Nomegestrol acetate: pharmacology, safety profile and therapeutic efficacy.
Topics: Animals; Bone Remodeling; Breast Neoplasms; Cardiovascular Diseases; Contraceptives, Oral, Hormonal; Endometrial Hyperplasia; Female; Hormone Replacement Therapy; Humans; Megestrol; Norpregnadienes; Progesterone Congeners; Risk Assessment; Risk Factors; Thromboembolism; Treatment Outcome | 2010 |
Insulin sensitivity and cardiovascular risk factors in ovariectomized monkeys with estradiol alone or combined with nomegestrol acetate.
Topics: Administration, Oral; Animals; Aorta, Thoracic; Cardiovascular Diseases; Cholesterol; Dinoprost; Drug Combinations; Estradiol; Female; Insulin Resistance; Macaca fascicularis; Megestrol; Norpregnadienes; Ovariectomy; Risk Factors | 1998 |
[What's new in hormone replacement therapy for postmenopausal women? I. Advantages of hormone replacement therapy (HRT)].
Topics: Aged; Alzheimer Disease; Cardiovascular Diseases; Cholesterol, HDL; Depression; Dyspareunia; Estrogen Replacement Therapy; Female; Humans; Male; Megestrol; Middle Aged; Norpregnenes; Osteoporosis; Postmenopause; Progesterone Congeners | 2000 |
3 trial(s) available for megestrol and Cardiovascular Diseases
| Article | Year |
|---|---|
Cardiovascular risk factors and combined estrogen-progestin replacement therapy: a placebo-controlled study with nomegestrol acetate and estradiol.
Topics: Apoproteins; Blood Glucose; Blood Pressure; Cardiovascular Diseases; Cholesterol; Double-Blind Method; Drug Combinations; Estradiol; Estrogen Replacement Therapy; Female; Fibrinogen; Follicle Stimulating Hormone; Humans; Lipoproteins; Megestrol; Middle Aged; Norpregnadienes; Plasminogen; Progesterone Congeners; Prospective Studies; Renin; Risk Factors; Triglycerides | 1995 |
High- versus standard-dose megestrol acetate in women with advanced breast cancer: a phase III trial of the Piedmont Oncology Association.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Cardiovascular Diseases; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged; Survival Rate; Weight Gain | 1990 |
Medical castration using megestrol acetate and minidose estrogen.
Topics: Adenocarcinoma; Administration, Oral; Aged; Aged, 80 and over; Cardiovascular Diseases; Clinical Trials as Topic; Diethylstilbestrol; Drug Combinations; Estradiol Congeners; Ethinyl Estradiol; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Megestrol; Megestrol Acetate; Middle Aged; Orchiectomy; Prostatic Neoplasms; Time Factors | 1988 |